CONCLUSIONS: Evaluation of the experimental data showed that k(L)a values were affected by process
variables. Besides the major exponential correlations used in the literature, satisfactory linear correlations for the relationship between the k(L)a and process variables were obtained. (C) 2010 Society of Chemical Industry”
“Dysregulated centrosomal expression has been observed in high grade gliomas. Thus, this study aimed to examine the expression of Aurora family kinase and various centrosomal proteins, including centrin, ?-tubulin, and hNinein isoforms, in human brain tumors, including 29 meningiomas, 34 astrocytomas, 6 pituitary adenomas, and 6 metastatic tumors. mRNA expression was evaluated using reverse transcription polymerase chain reaction. Adriamycin The role of hNinein isoform 6 expression in cell differentiation was assessed in BrdU-treated IMR-32 cells. Differential expression of centrosomal proteins of brain tumors and cell lines was observed. Specifically, centrin 2 and centrin 3 expression levels were classified as moderate or abundant in >97% of samples in the meningioma group, 63% of astrocytomas, >83% of metastatic and pituitary tumors. Alternatively, hNinein isoform 6 expression was only detected in normal brain and astrocytoma tumors (17/34); however, it was not expressed in meningioma (0/29), metastatic
tumors (0/6) (P < 0.001). Of the six neuroblastoma cell lines analyzed AZD1208 only IMR-32 cells expressed hNinein isoform 6. Furthermore, downregulated expression of hNinein isoform 6 and upregulation of ?-tubulin was correlated to astrocytoma tumor grade (P < 0.001). Increased hNinein isoform 6 mRNA expression was observed in response to BrdU treatment, and its expression was greater in teratomas as compared to embryonic stem cells. Further studies are necessary to determine if hNinein isoform 6 functions as a tumor-suppressor gene
in brain tumors. Differential centrosomal protein expression may result in altered centrosome function that is observed the in progression of various brain tumors. (C) 2012 International Union of Biochemistry and Molecular Biology, Fludarabine JAK/STAT inhibitor Inc.”
“BACKGROUND: Biomass is the only renewable feedstock containing carbon, and therefore the only alternative to fossil-derived crude oil derivatives. However, the main problems concerning the application of biomass for biofuels and bio-based chemicals are related to transport and handling, the limited scale of the conversion process and the competition with the food industry. To overcome such problems, an integral processing route for the conversion of (non-feed) biomass (residues) to transportation fuels is proposed. It includes a pretreatment process by fast pyrolysis, followed by upgrading to produce a crude-oil-like product, and finally co-refining in traditional refineries.
RESULTS: This paper contributes to the understanding of pyrolysis oil upgrading.